Curcumin Terminated Phase 2 Trials for Bipolar Disorder (BD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01928043Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations